Trial of Rifaximin in the Treatment of Tropical Enteropathy
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether rifaximin is effective in the treatment of
tropical enteropathy in a population of African children at high risk for this disease.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
Baylor College of Medicine United States Department of Agriculture (USDA) University of Malawi College of Medicine